Morphine and morphine-6β-glucuronide-induced feeding are differentially reduced by G-protein α-subunit antisense probes in rats

Brain Research

Volumn 876, Issue 1-2, 2000, Pages 62-75

  Silva, Robert M ^a   Rossi, Grace C ^b,c   Mathis, John P ^b   Standifer, Kelly M ^d   Pasternak, Gavril W ^b   Bodnar, Richard J ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c LONG ISLAND UNIVERSITY   (United States)

^d UNIVERSITY OF HOUSTON   (United States)

Author keywords

Antisense oligodeoxynucleotides; Feeding; G protein subunits; Morphine; Morphine 6 glucuronide

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; MORPHINE; MORPHINE 6 GLUCURONIDE; MU OPIATE RECEPTOR; ANTISENSE OLIGONUCLEOTIDE; ISOPROTEIN; MORPHINE DERIVATIVE; MORPHINE-6-GLUCURONIDE;

ALPHA CHAIN; ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EXON; FEEDING BEHAVIOR; MALE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RAT; RECEPTOR BINDING; ANIMAL; BODY WEIGHT; DRUG EFFECT; EATING; GENETICS; SPRAGUE DAWLEY RAT;

ANIMALS; BODY WEIGHT; EATING; GTP-BINDING PROTEINS; MALE; MORPHINE; MORPHINE DERIVATIVES; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0034622666     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02621-4     Document Type: Article

References (66)

1. Abbott F.V., Palmour R.M. Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats. Life Sci. 43:1988;1685-1695.
2. Bare L.A., Mansson E., Yang D. Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain. FEBS Lett. 354:1994;213-216.
3. Bodnar R.J., Paul D., Rosenblum M., Liu L., Pasternak G.W. Blockade of morphine analgesia by both pertussis and cholera toxins in the periaqueductal gray and locus coeruleus. Brain Res. 529:1990;324-328.
4. 3H]Morphine-6β-glucuronide binding in brain membranes and a MOR-1-transfected cell line. J. Pharmacol. Exp. Ther. 282:1997;1291-1297.
5. Burdick K., Yu W.-Z., Ragnauth A., Moroz M., Pan Y.X., Rossi G.C., et al. Antisense mapping of opioid receptor clones: effects upon 2-deoxy-D-glucose-induced hyperphagia. Brain Res. 794:1998;359-363.
6. Chen Y., Mestek A., Liu J., Hurley A., Yu L. Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol. Pharmacol. 44:1993;8-12.
7. Childers S.R. Opiate-inhibited adenylate cyclase in rat brain membranes depleted of Gs-stimulated adenylate cyclase. J. Neurochem. 50:1988;543-553.
8. Christiansen C.B., Jorgensen L.N. Morphine-6-glucuronide has high affinity for the opioid receptor. Pharmacol. Toxicol. 60:1987;75-76.
9. Cruciani R.A., Rossi G.C., Pasternak G.W. Antisense oligonucleotides to Gs prevents the decline of morphine analgesia over time in mice. Soc. Neurosci. Abs. 25:1999;1478.
10. Frances B., Gout R., Monsarrat B., Cros J., Zajac J. Further evidence that morphine-6-glucuronide is a more potent opioid agonist than morphine. J. Pharmacol. Exp. Ther. 262:1992;25-31.
11. Garzon J., Martinez-Pena Y., Sanchez-Blazquez P. Dissimilar efficacy of opioids to produce mu-mediated analgesia: role of Gx/z and Gi2 transducer proteins. Life Sci. 55:1994;PL205-212.
12. Gilman A.G. G-proteins: transducers of receptor-generated signals. Annu. Rev. Biochem. 56:1987;615-649.
13. Goode T.L., Raffa R.B. An examination of the relationship between mu-opioid antinociceptive efficacy and G-protein coupling using pertussis and cholera toxins. Life Sci. 60:(7):1997;PL107-113.
14. Gosnell B.A., Levine A.S. Stimulation of ingestive behaviour by preferential and selective opioid agonists. Cooper S.J., Clifton P.G. Drug Receptor Subtypes and Ingestive Behaviour. 1996;147-166 Academic Press, London.
15. Guvakova M.A., Yakubov L.A., Vlodavsky I., Tonkinson J.L., Stein C.A. Phosphorothioate oligodeoxynucleotides bind to fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix. J. Biol. Chem. 270:1995;2620-2627.
16. Hildebrandt J.D., Sekura R.D., Codina J., Iyengar R., Manclark C.R., Birnbaumer L., et al. Stimulation and inhibition of adenyl cyclases mediated by distinct regulatory proteins. Nature. 302:1983;706-709.
17. Inturrisi C.E., Yoburn B.C., Portenoy R.K., Foley K.M. Species dependent formation of morphine-6-glucuronide (M-6-G) from morphine (MOR). Committee Prob. Drug Depend. 174:1996;157.
18. Jaffe J.H., Martin W.R. Opioid analgesics and antagonists. Gilman A.G., Goodman L.S., Gilman A. The Pharmacological Basis of Therapeutics. 1985;491-532 MacMillan, New York.
19. Jurna I., Baldauf J., Fleischer W. Depression by morphine-6-glucuronide of nociceptive activity in rat thalamus neurons: comparison with morphine. Brain Res. 722:1996;132-138.
20. Katada I., Ui M. Islet-activating protein: a modifier of receptor-activated regulation of rat adenylate cyclase. J. Biol. Chem. 256:1981;8310-8317.
21. Lai H.W., Minami M., Satoh M., Wong Y.H. Gz coupling to the rat kappa-opioid receptor. FEBS Lett. 360:1995;97-99.
22. Leventhal L., Cole J.L., Rossi G.C., Pan Y.X., Pasternak G.W., Bodnar R.J., et al. Antisense oligodeoxynucleotides against the MOR-1 clone alter weight and ingestive responses in rats. Brain Res. 719:1996;78-84.
23. Leventhal L., Silva R.M., Rossi G.C., Pasternak G.W., Bodnar R.J. Morphine-6beta-glucuronide-induced hyperphagia: characterization of opioid action by selective antagonists and antisense mapping in rats. J. Pharmacol. Exp. Ther. 287:1998;538-544.
24. Leventhal L., Stevens L.B., Rossi G.C., Pasternak G.W., Bodnar R.J. Antisense mapping of the MOR-1 opioid receptor clone: modulation of hyperphagia induced by DAMGO. J. Pharmacol. Exp. Ther. 282:1997;1402-1407.
25. Levine A.S., Grace M., Portoghese P.S., Billington C.J. The effect of selective opioid antagonists on butorphanol-induced feeding. Brain Res. 637:1994;242-248.
26. Levine A.S., Morley J.E. Butorphenol tartrate induces feeding in rats. Life Sci. 32:1983;781-785.
27. Mann P.E., Arjune D., Romero M.T., Pasternak G.W., Hahn E.F., Bodnar R.J., et al. Differential sensitivity of opioid-induced feeding to naloxone and naloxonazine. Psychopharmacology. 94:1988;330-341.
28. Misawa H., Ueda H., Katada T., Ui M., Satoh M. A subtype of opioid kappa-receptor is coupled to inhibition of Gi1-mediated phospholipase c activity in the guinea pig cerebellum. FEBS Lett. 361:1995;106-110.
29. Miyamae T., Fukushima N., Misu Y., Ueda H. Delta opioid receptor mediates phospholipase C activation via Gi in Xenopus oocytes. FEBS Lett. 333:1993;311-314.
30. Myers K.J., Dean N.M. Sensible use of antisense: how to use oligonucleotides as research tools. Trends Pharmacol. Sci. 21:(1):2000;19-23.
31. Pan Y.X., Xu J., Bolan E., Abbadie C., Chang A., Zuckerman A., et al. Identification and characterization of three new alternatively spliced MOR-1 opioid receptor isoforms. Mol. Pharmacol. 56:1999;396-403.
32. Pasternak G.W., Bodnar R.J., Clark J.A., Inturrisi C.E. Morphine-6-glucuronide, a potent mu agonist. Life Sci. 41:1987;2845-2849.
33. Pasternak G.W., Standifer K.M. Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology. Trends Pharmacol. Sci. 16:1995;344-350.
34. Paul D., Standifer K.M., Inturrisi C.E., Pasternak G.W. Pharmacological characterization of morphine-6beta-glucuronide, a very potent morphine metabolite. J. Pharmacol. Exp. Ther. 251:1989;477-483.
35. Perez J.R., Li Y., Stein C.A., Majumder S., van Oorschot A., Narayanan R. Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides. Proc. Natl. Acad. Sci. USA. 91:1994;5957-5961.
36. Piros E.T., Prather P.L., Loh H.H., Law P.Y., Evans C.J., Hales T.G., et al. Calcium channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells. Mol. Pharmacol. 47:1995;1041-1049.
37. Raffa R.B., Goode T.L., Martinez R.P., Jacoby H.L. A Gi2 antisense oligonucleotide differentiates morphine antinociception, constipation and acute dependence in mice. Life Sci. 58:1996;PL 73-76.
38. Raffa R.B., Martinez R.P., Connelly C.D. G-protein antisense oligodeoxynucleotides and mu-opioid supraspinal antinociception. Eur. J. Pharmacol. 258:1994;R5-R7.
39. Reisine T., Bell G.I. Molecular biology of opioid receptors. Trends Neurosci. 16:1993;506-510.
40. Roerig S.C. Opioid regulation of second messenger systems. Analgesia. 3:1998;231-250.
41. Ross E.M. Signal sorting and amplification through G-protein-coupled receptors. Neuron. 3:1989;141-152.
42. Rossi G.C., Brown G.P., Leventhal L., Yang K., Pasternak G.W. Novel receptor mechanisms for heroin and morphine-6-glucuronide analgesia. Neurosci. Lett. 216:1996;1-4.
43. Rossi G.C., Leventhal L., Pan Y.-X., Cole J., Su W., Bodnar R.J., et al. Antisense mapping of MOR-1 in rats: distinguishing between morphine and morphine-6beta-glucuronide antinociception. J. Pharmacol. Exp. Ther. 281:1997;109-114.
44. Rossi G.C., Pan Y.X., Brown G.P., Pasternak G.W. Antisense mapping the MOR-1 receptor: evidence for alternative splicing and a novel morphine-6Beta-glucuronide receptor. FEBS Lett. 369:1995;192-196.
45. Rossi G.C., Pasternak G.W. Establishing the molecular biology of opioid behavior through antisense approaches. Weiss B. Antisense Oligodeoxynucleotides and Antisense RNA. 1997;115-130 CRC Press, Boca Raton, FL.
46. Rossi G.C., Standifer K.M., Pasternak G.W. Differential blockade of morphine and morphine-6-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats. Neurosci. Lett. 198:1995;99-102.
47. Sanchez-Blazquez P., Garcia-Espana A., Garzon J. In vivo injection of oligodeoxynucleotides to G-alpha subunits and supraspinal analgesia evoked by mu and delta opioid agonists. J. Pharmacol. Exp. Ther. 275:1995;1590-1596.
48. Sanchez-Blazquez P., Garzon J. Intracerebroventricular injection of antibodies directed against Gs enhances the supraspinal antinociception induced by morphine, beta-endorphin and clonidine in rats. Life Sci. 51:1992;PL237-242.
49. Sanchez-Blazquez P., Juarros J.L., Martinez-Pena Y., Castro M.A., Garzon J. Gx/z and Gi2 transducer proteins on mu/delta opioid-mediated supraspinal antinociception. Life Sci. 53:1993;PL381-386.
50. Sanger D.J., McCarthy P.S. Differential effects of morphine on food and water intake in food deprived and freely feeding rats. Psychopharmacology. 72:1980;103-106.
51. Schuller A.G., King M.A., Zhang J., Bolan E., Pan Y.X., Morgan D.J., et al. Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1. Nat. Neurosci. 2:1999;151-156.
52. Selbie L.A., Hill S.J. G-protein-coupled-receptor cross-talk: the fine tuning of multiple receptor-signalling pathways. Trends Pharmacol. Sci. 19:1998;87-93.
53. Shimomura K., Kamata O., Ueki S., Ida S., Oguri K., Yoshimura H., et al. Analgesic effects of morphine glucuronides. Tokohu J. Exp. Med. 105:1971;45-52.
54. Standifer K.M., Pasternak G.W. G-proteins and opioid receptor-mediated signalling. Cell Signal. 9:1997;237-248.
55. Standifer K.M., Rossi G.C., Pasternak G.W. Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G-protein alpha subunits. Mol. Pharmacol. 50:1996;293-298.
56. Stein J.A., Znamensky V., Baumer F., Rossi G.C., Pasternak G.W., Bodnar R.J., et al. Mercaptoacetate induces feeding through central opioid-mediated mechanisms in rats. Brain Res. 864:2000;240-251.
57. Stryer L., Bourne H.R. G proteins: a family of signal transducers. Annu. Rev. Cell Biol. 2:1986;391-419.
58. Sullivan A.F., McQuay H.J., Bailey D., Dickenson A.H. The spinal antinociceptive actions of morphine metabolites, morphine-6-glucuronide and normorphine in the rat. Brain Res. 482:1989;219-224.
59. Tang T.L., Kiang J.G., Cote T.E., Cox B.M. Antisense oligodeoxynucleotide to the Gi2 protein alpha subunit sequence inhibits an opioid-induced increase in the intracellular free calcium concentration in ND8-47 neuroblastoma X dorsal root ganglion hybrid cells. Mol. Pharmacol. 48:1995;189-193.
60. Taussig R., Gilman A.G. Mammalian membrane-bound adenylyl cyclases. J. Biol. Chem. 270:(1):1995;1-4.
61. Thornhill J.A., Hirst M., Gowdey C.W. Disruption of diurnal feeding patterns of rats by heroin. Pharmacol. Biochem. Behav. 4:1976;129-135.
62. Tsu R.C., Chan J.S., Wong Y.H. Regulation of multiple effectors by the cloned delta-opioid receptor: stimulation of phospholipase C and type II adenylyl cyclase. J. Neurochem. 64:1995;2700-2707.
63. Uhl G.R., Childers S.R., Pasternak G.W. An opiate receptor gene family reunion. Trends Neurosci. 17:1994;89-93.
64. Wang J.-B., Mei Y., Eppler C.M., Gregor P., Spivak C.E., Uhl G.R., et al. Mu opiate receptor: cDNA cloning and expression. Proc. Natl. Acad. Sci. USA. 90:1993;10230-10234.
65. Yakubov L., Khaled Z., Zhang L.M., Truneh A., Vlassov V., Stein C.A., et al. Oligodeoxynucleotides interact with recombinant CD4 at multiple sites. J. Biol. Chem. 268:1993;18818-18823.
66. Zimprich A., Simon T., Hollt V. Cloning and expression of an isoform of the rat mu opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1. FEBS Lett. 352:1995;142-146.